Back to Journals » Vascular Health and Risk Management » Volume 12

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab

Total article views   HTML views PDF downloads Totals
17,208 Dovepress* 13,247+ 2,400 15,647
PubMed Central* 3,961 1,173 5,134
Totals 17,208 3,573 20,781
*Since 9 May 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 3 6

View citations on PubMed Central and Google Scholar